2Carbone M,Fera MT,Pennisi MG,et al.Activity of nine fluoroquinolones against strains of Bordetella bronchiseptica[J].Int J Antimicrob Agents,1999,12:355-8.
3Chfistiansen K.Fusidic acid non antibacterial activity[J].Int J Antimi-crob Agents,1999,12:73.
5Koning S,Van Suijlekom-Smit LW,Nouwen JL,et al.Fusidic acid cream in the treatment of impetigo in general practice:double blind randomised placebo controlled trial[J].BMJ,2001,324(7331):203-6.
4Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States ,2001 - 2004 [ J ]. J Infect Dis ,2008,197 (9) : 1235 - 43.
5Chen CJ, Huang YC, Chiu CH, et al. Clinical features and genotyping analysis of community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwan Residents children [ J ]. Pediatr Infect Dis J . 2005,24:40 - 5.
1Liu Y, Geng W, Yang Y, et al. Susceptibility to and resistance determinants of fusidic acid in Staphylococcus attreus isolated from Chinese children with skin and soft tissue infections [J]. FEMS Im- munol Med Microbiol, 2012, 64 (2) : 212-218.
2Park MR, Kim DS, Kim J, et al. Anaphylaxis to topically ap- plied sodium fusidate [J]. Allergy Asthma Immunol Res, 2013, 5 (2) : 110-112.
3Kraus CN, Burnstead BW. The safety record of fusidic acid in non-US markets: a focus on skin infections [J]. Clin Infect Dis, 2011, 52 (7) : S527-S537.
4Schefer H, Simonsen L. Fusidic acid in dermatology: an updated review [J].EurJDermatol, 2010, 20 (1) : 6-15.
5Koning S, Van Suijlekom-Smit LW, Nouwen JL, et al. Fusidic acid cream in the treatment of impetigo in general practice : double blind randomised placebo controlled trial [J]. BMJ, 2002, 324 (7331) : 203-206.
6Koning S, Van SR, Verhagen AP, et al. Interventions for impeti- go [J]. Cochrane Database Syst Rev, 2012, ( 1 ) : CD003261.
7Koning S, Van Suijlekom-Smit LW, Nouwen JL, et al. Fusidic acid cream in the treatment of in petigo in general practice double blind random ised placebo con trolled trial [J]. BMJ, 2001, 324 ( 7331 ) : 203-206.
8Liu Y, Kong F, Zhang X, et al. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin- resistant Staphylococcus aureus to be uncommon and heterogene- ous [J]. Br J Dermatol, 2009, 161 (6) : 1347-1350.
9Katopodis GD, Grivea IN, Tsantsaridou AJ, et al. Fusidicacid and clindamycin resistance in community-associated, methicillin- resistant Staphylococcus aureus infections inchildren of Central Greece [J]. BMC Infect Dis, 2010, 10: 351.
10Heng YK, Tan KT, Sen P, et al. Staphylococcus aureus and topical fusidic acid use: results of a clinical audit on antimicrobial resistance [J]. Int J Dermatol, 2013, 52 ( 7 ) : 876-881.
